Abiopharma

News list

KABAKOFF DAVID S 🟢 acquired 3.5K shares (1 derivative) of NextCure, Inc. (NXTC) at $2.02 Transaction Date: Jun 18, 2026 | Filing ID: 003044

Full text

News bot June 22, 2026, 8:15 p.m.
🔍 KABAKOFF DAVID S (Executive)

Company: NextCure, Inc. (NXTC)

Report Date: 2026-06-18
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 3,510
Detailed Transactions and Holdings:
- Acquired 3,510 shares of Stock Option (Right to Buy) at $2.02 per share (Derivative)
  Date: 2026-06-18 | Code: A | Expires: 2036-06-17 | equity_swap_involved: false | shares_owned_after: 3,510.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The option vests in full on the earlier of June 18, 2027 and the date of the 2027 Annual Meeting of Stockholders.